Hiyashree Sharmah

Hiyashree Sharmah

Auto-generated profile, based on publicly available information

Hiyashree Sharmah

School of Pharmacy, Pragjyotishpur University, Chandrapur, Guwahati, Kamrup (M), India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in Computational Biology and Chemistry
Verified
Journal Article
Closed access
LALokman Ali Ahmed
Lokman Ali Ahmed
BDBabita Deka
Babita Deka
HSHiyashree Sharmah
Hiyashree Sharmah
PPPooja Patowary
Pooja Patowary
BSBhargab Jyoti Sahariah
Bhargab Jyoti Sahariah
ATApurba Talukdar
Apurba Talukdar

14 August 2025 in Journal of the Indian Chemical Society
Verified
Journal Article
Closed access
HSHiyashree Sharmah
Hiyashree Sharmah
PPPooja Patowary
Pooja Patowary
LALokman Ali Ahmed
Lokman Ali Ahmed
BDBabita Deka
Babita Deka
AMAbu Saif Mustaque
Abu Saif Mustaque
BSBhargab Jyoti Sahariah
Bhargab Jyoti Sahariah

13 December 2025 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
HSHiyashree Sharmah
Hiyashree Sharmah
LALokman Ali Ahmed
Lokman Ali Ahmed
BDBabita Deka
Babita Deka
DBDeepsikha Bharali
Deepsikha Bharali
BGBitu Gogoi
Bitu Gogoi
PPPooja Patowary
Pooja Patowary
Coumarin and indole derivatives occupy a prominent place in medicinal chemistry due to their diverse pharmacological activities, including anticancer, antimicrobial, antidiabetic, antiviral, and neuroprotective effects. Molecular hybridization, which combines two bioactive scaffolds into a single framework, has emerged as an effective strategy to improve potency, selectivity, and multifunctionality. In this context, coumarin–indole hybrids have attracted significant attention; however, no focused review has yet addressed their synthetic development. This review seeks to fill that gap by providing a critical overview of the synthetic methodologies, structure–activity relationships, and pharmacological profiles of coumarin–indole hybrids. The strategic fusion of these two privileged scaffolds has yielded compounds with notable preclinical efficacy in oncology, infectious diseases, metabolic disorders, and neurodegenerative disorders. Nevertheless, challenges such as poor bioavailability, limited target selectivity, and insufficient in vivo validation remain obstacles to clinical translation. Future progress will require structural optimization, prodrug strategies, advanced delivery systems, and systematic pharmacological and toxicological investigations. Overall, coumarin–indole hybrids represent a versatile chemotype with strong potential for the discovery of next-generation therapeutics across multiple disease domains. Graphical Abstract

2 July 2025 in Brain Disorders
Verified
Journal Article
Open access
LALokman Ali Ahmed
Lokman Ali Ahmed
HSHiyashree Sharmah
Hiyashree Sharmah

4 March 2026 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
HSHiyashree Sharmah
Hiyashree Sharmah
LALokman Ali Ahmed
Lokman Ali Ahmed
DKDurgaprasad Kemisetti
Durgaprasad Kemisetti
SKSuresh Kumar
Suresh Kumar
KSKumara Swamy Samanthula
Kumara Swamy Samanthula
NGNiladry Sekhar GHOSH
Niladry Sekhar GHOSH